Inventor · disambiguated record
Mariusz A. Wasik
Also filed as: WASIK MARIUSZ · WASIK MARIUSZ A
9 granted patents·5 pending applications·23 citations·filing 2002–2019
83Inventor score
Top patents by PatentIndex Score
14 records- 0195US10357514B2Treatment of cancer using anti-CD19 Chimeric Antigen ReceptorUNIV PENNSYLVANIA·Filed 2015·Granted Jul 23, 2019·18 cites·45 claims
- 0275US7781447B2O-methylated rapamycin derivatives for alleviation and inhibition of lymphoproliferative disordersUNIV PENNSYLVANIA·Filed 2007·Granted Aug 24, 2010·2 cites·8 claims
- 0372US9486469B2STAT5a and its functional tumor suppressor analogs for treatment of malignancies expressing NPM/ALK and other oncogenic kinasesWASIK MARIUSZ A·Filed 2008·Granted Nov 8, 2016·1 cites·11 claims
- 0464US7754734B2O-methylated rapamycin derivatives for alleviation and inhibition of lymphoproliferative disordersUNIV PENNSYLVANIA·Filed 2002·Granted Jul 13, 2010·2 cites·15 claims
- 0562US9255279B2Anaplastic lymphoma kinase (ALK) as an oncogene capable of transforming normal human cellsUNIV PENNSYLVANIA·Filed 2014·Granted Feb 9, 2016·0 cites·3 claims
- 0662US2019388471A1Treatment of cancer using anti-cd19 chimeric antigen receptorNOVARTIS AG·Filed 2019·Application pending·0 cites
- 0758US10166251B2STAT5a and its functional tumor suppressor analogs for treatment of malignancies expressing NPM/ALK and other oncogenic kinasesUNIV PENNSYLVANIA·Filed 2016·Granted Jan 1, 2019·0 cites·12 claims
- 0857US2020016182A1STAT5a AND ITS FUNCTIONAL TUMOR SUPPRESSOR ANALOGS FOR TREATMENT OF MALIGNANCIES EXPRESSING NPM/ALK AND OTHER ONCOGENIC KINASESUNIV PENNSYLVANIA·Filed 2018·Application pending·0 cites
- 0956US8759370B2O-methylated rapamycin derivatives for alleviation and inhibition of lymphoproliferative disordersWASIK MARIUSZ A·Filed 2010·Granted Jun 24, 2014·0 cites·12 claims
- 1050US8778961B2O-methylated rapamycin derivatives for alleviation and inhibition of lymphoproliferative disordersWASIK MARIUSZ A·Filed 2010·Granted Jul 15, 2014·0 cites·4 claims
- 1150US8569332B2O-methylated rapamycin derivatives for alleviation and inhibition of lymphoproliferative disordersWASIK MARIUSZ A·Filed 2010·Granted Oct 29, 2013·0 cites·2 claims
- 1249US2016194616A1Anaplastic Lymphoma Kinase (ALK) As An Oncogene Capable Of Transforming Normal Human CellsUNIV PENNSYLVANIA·Filed 2015·Application pending·0 cites
- 1336US2012201824A1Compositions and Methods for Inhibiting an Oncogenic Protein to Enhance ImmunogenicityWASIK MARIUSZ·Filed 2011·Application pending·0 cites
- 1433US2018140602A1Combination of chimeric antigen receptor therapy and amino pyrimidine derivativesANGST DANIELA·Filed 2016·Application pending·0 cites
Join the waitlist — get patent alerts
Get an alert when Mariusz A. Wasik files or is granted a new patent.
We store only your email — no account needed. See our privacy policy.
Identity basis: PatentsView inventor disambiguation (2025Q4-odp release). How scoring works →